{"id":"high-dose-gonadotropins","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Ovarian hyperstimulation syndrome (OHSS)"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Abdominal bloating and discomfort"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Gonadotropins (FSH and/or hCG) are hormones that directly stimulate follicle development and maturation in the ovaries during controlled ovarian hyperstimulation. This allows retrieval of multiple oocytes for in vitro fertilization or other fertility treatments. The high doses override natural feedback inhibition to achieve supraphysiologic hormone levels and multifollicular development.","oneSentence":"High dose gonadotropins stimulate the ovaries to produce multiple mature eggs for assisted reproductive procedures.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:47:44.737Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Controlled ovarian hyperstimulation for in vitro fertilization (IVF)"},{"name":"Assisted reproductive technology (ART) procedures"}]},"trialDetails":[{"nctId":"NCT05123040","phase":"PHASE1, PHASE2","title":"Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2023-06-05","conditions":"Acute-graft-versus-host Disease","enrollment":10},{"nctId":"NCT06282588","phase":"PHASE2, PHASE3","title":"Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers","status":"RECRUITING","sponsor":"Cancer Research Antwerp","startDate":"2023-12-13","conditions":"Prostate Cancer","enrollment":493},{"nctId":"NCT07027124","phase":"PHASE2","title":"Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2026-03-19","conditions":"Prostate Cancer, High-risk Prostate Cancer","enrollment":40},{"nctId":"NCT02871167","phase":"NA","title":"Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2016-12","conditions":"Breast Cancer","enrollment":140},{"nctId":"NCT07476001","phase":"PHASE2","title":"Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2026-03","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":12},{"nctId":"NCT04037254","phase":"PHASE1, PHASE2","title":"Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring","status":"COMPLETED","sponsor":"NRG Oncology","startDate":"2019-10-08","conditions":"Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8","enrollment":22},{"nctId":"NCT07319429","phase":"PHASE2, PHASE3","title":"Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification","status":"RECRUITING","sponsor":"Fudan University","startDate":"2026-01-25","conditions":"Endometrial Cancer, Fertility","enrollment":260},{"nctId":"NCT06379217","phase":"PHASE1","title":"NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-07-29","conditions":"Metastatic Neuroendocrine Prostate Cancer","enrollment":31},{"nctId":"NCT00936390","phase":"PHASE3","title":"Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2009-09","conditions":"Prostate Cancer","enrollment":1538},{"nctId":"NCT01546987","phase":"PHASE3","title":"Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2012-05","conditions":"Prostate Cancer","enrollment":239},{"nctId":"NCT07455903","phase":"PHASE2","title":"Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT","status":"NOT_YET_RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2026-04","conditions":"Prostate Cancer, Localized Prostate Carcinoma","enrollment":50},{"nctId":"NCT05617885","phase":"PHASE1","title":"Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Praful Ravi, MB BCHir, MRCP","startDate":"2023-08-09","conditions":"Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer","enrollment":9},{"nctId":"NCT03388619","phase":"PHASE1","title":"Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2018-01-17","conditions":"Cancer Of Prostate, Prostate Neoplasms, Prostate Cancer","enrollment":30},{"nctId":"NCT07158021","phase":"PHASE2","title":"Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial","status":"RECRUITING","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2026-01-22","conditions":"Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8","enrollment":75},{"nctId":"NCT06631521","phase":"PHASE1","title":"Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer","status":"RECRUITING","sponsor":"AdventHealth","startDate":"2024-10-22","conditions":"Prostate CA, Prostate Cancer (Adenocarcinoma), Prostate Cancer Surgery","enrollment":30},{"nctId":"NCT06001762","phase":"PHASE2","title":"TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2023-10-05","conditions":"Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma","enrollment":90},{"nctId":"NCT06059118","phase":"PHASE2","title":"Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2023-10-04","conditions":"Prostate Cancer","enrollment":50},{"nctId":"NCT00329043","phase":"PHASE2","title":"Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-05-15","conditions":"Prostate Cancer","enrollment":64},{"nctId":"NCT03009981","phase":"PHASE3","title":"A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer","status":"COMPLETED","sponsor":"Alliance Foundation Trials, LLC.","startDate":"2017-03-06","conditions":"Prostate Cancer","enrollment":504},{"nctId":"NCT04025372","phase":"PHASE2","title":"INTREPId (INTermediate Risk Erection PreservatIon Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2020-06-01","conditions":"Prostate Cancer","enrollment":234},{"nctId":"NCT05873725","phase":"","title":"Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin","status":"COMPLETED","sponsor":"Clinique Ovo","startDate":"2023-05-20","conditions":"IVF, Infertility","enrollment":118},{"nctId":"NCT05189457","phase":"PHASE2","title":"First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2022-01-25","conditions":"Prostate Cancer, Stage IV Prostate Cancer","enrollment":32},{"nctId":"NCT06348264","phase":"PHASE2","title":"Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma","status":"RECRUITING","sponsor":"Peking University First Hospital","startDate":"2024-10-10","conditions":"Salivary Gland Neoplasm Duct","enrollment":37},{"nctId":"NCT03860987","phase":"PHASE2","title":"Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-04-30","conditions":"Castrate Sensitive Prostate Cancer","enrollment":12},{"nctId":"NCT01492972","phase":"PHASE3","title":"Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer","status":"RECRUITING","sponsor":"Proton Collaborative Group","startDate":"2012-01","conditions":"Prostate Cancer","enrollment":192},{"nctId":"NCT03630666","phase":"NA","title":"Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2018-12-04","conditions":"Prostate Cancer, Oligometastasis","enrollment":256},{"nctId":"NCT07121751","phase":"PHASE4","title":"Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)","status":"NOT_YET_RECRUITING","sponsor":"Dunamenti REK Istenhegyi IVF Center","startDate":"2025-09-01","conditions":"Hypo-responder, Infertility (IVF Patients), OVARIAN STIMULATION","enrollment":150},{"nctId":"NCT06997900","phase":"PHASE2","title":"Menopur And Rekovelle Combination Study Version 2.0","status":"RECRUITING","sponsor":"Clinique Ovo","startDate":"2025-07-04","conditions":"IVF, Controlled Ovarian Simulation, Fertility Disorders","enrollment":200},{"nctId":"NCT04181203","phase":"PHASE3","title":"Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNICANCER","startDate":"2020-01-09","conditions":"Prostate Cancer","enrollment":490},{"nctId":"NCT07076719","phase":"","title":"Cell-free DNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for Preimplantation Genetic Diagnosis","status":"COMPLETED","sponsor":"Sohag University","startDate":"2023-10-01","conditions":"to Evaluate the Feasibility and Accuracy of Using cfDNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for PGD","enrollment":20},{"nctId":"NCT06953882","phase":"PHASE2","title":"Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-07-09","conditions":"HER2 Negative Breast Cancer","enrollment":140},{"nctId":"NCT04760691","phase":"PHASE1","title":"Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2021-03-01","conditions":"Hiv, Prophylaxis, Transgender","enrollment":13},{"nctId":"NCT04194554","phase":"PHASE1, PHASE2","title":"A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2020-11-06","conditions":"Prostate Cancer","enrollment":102},{"nctId":"NCT06966219","phase":"","title":"Trigger Protocol on the Rate of Pregnancy After Intracytoplasmic Sperm Injection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suez University","startDate":"2025-05-01","conditions":"Infertility","enrollment":90},{"nctId":"NCT02346253","phase":"NA","title":"High-Dose Brachytherapy in Treating Patients With Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stanford University","startDate":"2015-01-13","conditions":"Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer","enrollment":146},{"nctId":"NCT06582446","phase":"PHASE2","title":"Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial)","status":"RECRUITING","sponsor":"German Oncology Center, Cyprus","startDate":"2024-09-16","conditions":"Prostate Cancer","enrollment":30},{"nctId":"NCT05473273","phase":"","title":"Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2023-04-24","conditions":"Infertility, Female","enrollment":40},{"nctId":"NCT06778733","phase":"EARLY_PHASE1","title":"Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders","status":"COMPLETED","sponsor":"University of Athens","startDate":"2022-01-01","conditions":"Female Infertility","enrollment":22},{"nctId":"NCT05330130","phase":"PHASE1","title":"Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells","status":"COMPLETED","sponsor":"ART Fertility Clinics LLC","startDate":"2023-07-05","conditions":"Ovarian Function Insufficiency, Fertility Issues, Infertility,Female","enrollment":6},{"nctId":"NCT05103228","phase":"NA","title":"Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders","status":"COMPLETED","sponsor":"Peter Kovacs MD","startDate":"2021-12-02","conditions":"Infertility, Ovarian Dysfunction","enrollment":190},{"nctId":"NCT02685397","phase":"PHASE2, PHASE3","title":"Management of Castration-Resistant Prostate Cancer with Oligometastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2016-10","conditions":"Castration-resistant Prostate Cancer Patients with Oligometastases","enrollment":102},{"nctId":"NCT01767090","phase":"PHASE2","title":"A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2012-12-04","conditions":"Endometriosis","enrollment":912},{"nctId":"NCT03047330","phase":"PHASE4","title":"Menopausal Sleep Fragmentation and Body Fat Gain","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2017-07-15","conditions":"Menopause","enrollment":41},{"nctId":"NCT06486870","phase":"PHASE3","title":"Comparison Between Two Ovulation Induction Therapies and LOD on Clinical Outcomes in CC-Resistant PCOS Women","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-01-01","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries","enrollment":183},{"nctId":"NCT04671966","phase":"PHASE4","title":"Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction","status":"UNKNOWN","sponsor":"The University of Texas at Arlington","startDate":"2018-09-13","conditions":"Heart Diseases, Left Ventricular Dysfunction","enrollment":100},{"nctId":"NCT00099086","phase":"PHASE1","title":"Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2007-01-16","conditions":"Prostate Cancer","enrollment":20},{"nctId":"NCT02543255","phase":"PHASE2","title":"Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2016-09","conditions":"Prostate Cancer","enrollment":76},{"nctId":"NCT05851547","phase":"PHASE2","title":"Dose Escalation For INtraprostatic LEsions","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2023-11-23","conditions":"Prostatic Neoplasms","enrollment":54},{"nctId":"NCT02525029","phase":"PHASE1, PHASE2","title":"Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2016-03","conditions":"Graft vs Host Disease","enrollment":53},{"nctId":"NCT04242017","phase":"PHASE2, PHASE3","title":"Long-term Better Than Short-term ADT With Salvage RT","status":"RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2020-07-07","conditions":"Prostate Cancer","enrollment":394},{"nctId":"NCT02594072","phase":"NA","title":"Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT)","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2016-04","conditions":"Prostate Cancer","enrollment":80},{"nctId":"NCT00482807","phase":"PHASE1","title":"Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2004-08-31","conditions":"Prostate Cancer","enrollment":9},{"nctId":"NCT05937490","phase":"PHASE4","title":"Adenomyosis and ART","status":"UNKNOWN","sponsor":"Azienda Ospedaliero-Universitaria di Modena","startDate":"2023-03-27","conditions":"Adenomyosis","enrollment":500},{"nctId":"NCT05019846","phase":"PHASE3","title":"SRT Versus SRT+ADT in Prostate Cancer","status":"RECRUITING","sponsor":"Marco Lorenzo Bonu","startDate":"2021-09-30","conditions":"Prostate Cancer","enrollment":310},{"nctId":"NCT05003752","phase":"PHASE1, PHASE2","title":"Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"German Oncology Center, Cyprus","startDate":"2021-08-01","conditions":"Prostate Adenocarcinoma, Radiation Toxicity","enrollment":40},{"nctId":"NCT05713578","phase":"EARLY_PHASE1","title":"Efficacy and Safety of Apantamide Combined With Docetaxel and ADT vs. Apantamide Combined With ADT in Patients With High Tumor Burden mHSPC: a Multicenter and Prospective Cohort Study","status":"RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2023-03-01","conditions":"Cohort Studies","enrollment":220},{"nctId":"NCT04168892","phase":"","title":"Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response","status":"COMPLETED","sponsor":"Andros Day Surgery Clinic","startDate":"2019-09-20","conditions":"Ovarian Response","enrollment":160},{"nctId":"NCT04869371","phase":"PHASE2","title":"Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer","status":"UNKNOWN","sponsor":"Hongqian Guo","startDate":"2018-12-12","conditions":"Neoadjuvant Therapy \\ High Risk Prostate Cancer \\ Docetaxel","enrollment":75},{"nctId":"NCT04356430","phase":"PHASE2","title":"Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer","status":"UNKNOWN","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2019-04-01","conditions":"Prostate Cancer","enrollment":75},{"nctId":"NCT02789878","phase":"PHASE2","title":"Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer","status":"COMPLETED","sponsor":"Instituto do Cancer do Estado de São Paulo","startDate":"2019-01-24","conditions":"Prostate Cancer","enrollment":64},{"nctId":"NCT02716974","phase":"PHASE2","title":"A Study of Definitive Therapy to Treat Prostate Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2016-06","conditions":"Prostate Cancer","enrollment":26},{"nctId":"NCT02368964","phase":"NA","title":"IVF Treatment in Women With Immature Oocytes in Previous Cycle","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2015-02-01","conditions":"Infertility","enrollment":100},{"nctId":"NCT00288080","phase":"PHASE3","title":"Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2005-12","conditions":"Prostate Cancer","enrollment":612},{"nctId":"NCT02770391","phase":"PHASE2","title":"Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2016-10-17","conditions":"Prostate Cancer","enrollment":54},{"nctId":"NCT02268175","phase":"PHASE2","title":"Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2014-10","conditions":"Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer","enrollment":75},{"nctId":"NCT02626507","phase":"PHASE1","title":"Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer","status":"UNKNOWN","sponsor":"Hoffman Oncology","startDate":"2016-01","conditions":"Breast Cancer","enrollment":18},{"nctId":"NCT05112692","phase":"NA","title":"Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-11","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries","enrollment":200},{"nctId":"NCT02508636","phase":"PHASE2","title":"Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2015-12-22","conditions":"Prostatic Neoplasms, Pelvic Nodal","enrollment":11},{"nctId":"NCT03463252","phase":"PHASE2, PHASE3","title":"Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC","status":"RECRUITING","sponsor":"West China Second University Hospital","startDate":"2018-04-01","conditions":"Endometrial Cancer, Atypical Endometrial Hyperplasia","enrollment":224},{"nctId":"NCT02603679","phase":"PHASE2","title":"Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Thomas Hatschek","startDate":"2015-02","conditions":"Early-Stage Breast Carcinoma, Estrogen Receptor Positive Tumor","enrollment":181},{"nctId":"NCT04060043","phase":"EARLY_PHASE1","title":"Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer","status":"COMPLETED","sponsor":"CMX Research","startDate":"2017-02-21","conditions":"Prostate Cancer","enrollment":11},{"nctId":"NCT03541928","phase":"PHASE2","title":"Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery","status":"UNKNOWN","sponsor":"The Methodist Hospital Research Institute","startDate":"2018-08-02","conditions":"High-risk Prostate Cancer, Prostate Cancer","enrollment":60},{"nctId":"NCT00004054","phase":"PHASE3","title":"Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2000-01","conditions":"Prostate Cancer","enrollment":397},{"nctId":"NCT03373149","phase":"PHASE2","title":"Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response","status":"UNKNOWN","sponsor":"Riyadh Fertility and Reproductive Health center","startDate":"2017-11-29","conditions":"Infertility, Female","enrollment":228},{"nctId":"NCT04268927","phase":"PHASE2","title":"Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-04-01","conditions":"Infertility","enrollment":106},{"nctId":"NCT01374087","phase":"PHASE2","title":"Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer","status":"TERMINATED","sponsor":"Ipsen","startDate":"2011-11","conditions":"Prostate Cancer","enrollment":32},{"nctId":"NCT03483545","phase":"NA","title":"Menopur And Rekovelle Combination Study","status":"COMPLETED","sponsor":"Dr François Bissonnette","startDate":"2018-07-17","conditions":"Fertility Disorders","enrollment":160},{"nctId":"NCT03996993","phase":"","title":"Defining Recurrent Disease With Axumin™","status":"UNKNOWN","sponsor":"Cancer Center of Irvine","startDate":"2019-07-01","conditions":"Prostate Cancer, Prostate Adenocarcinoma","enrollment":20},{"nctId":"NCT02778919","phase":"PHASE2","title":"Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis","status":"COMPLETED","sponsor":"Kissei Pharmaceutical Co., Ltd.","startDate":"2016-05-09","conditions":"Endometriosis","enrollment":""},{"nctId":"NCT01696877","phase":"PHASE1, PHASE2","title":"A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2013-01-18","conditions":"Prostate Cancer Adenocarcinoma in Situ","enrollment":29},{"nctId":"NCT03684824","phase":"NA","title":"Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-09","conditions":"Invitro Fertilization","enrollment":100},{"nctId":"NCT00860158","phase":"PHASE2","title":"Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer","status":"TERMINATED","sponsor":"Noah Hahn, M.D.","startDate":"2009-03","conditions":"Prostate Cancer","enrollment":1},{"nctId":"NCT01496131","phase":"PHASE2","title":"Tecemotide (L-BLP25) in Prostate Cancer","status":"COMPLETED","sponsor":"EMD Serono","startDate":"2011-10-24","conditions":"Prostate Cancer","enrollment":28},{"nctId":"NCT02397551","phase":"PHASE4","title":"Three Small Doses of HCG Versus Booster Dose of HCG on Ovum Pickup Day","status":"COMPLETED","sponsor":"Cairo University","startDate":"2015-03","conditions":"Infertility","enrollment":200},{"nctId":"NCT02397642","phase":"NA","title":"Dual Trigger Versus Booster Dose of HCG","status":"COMPLETED","sponsor":"Cairo University","startDate":"2015-03","conditions":"Infertility","enrollment":200},{"nctId":"NCT03397537","phase":"PHASE2","title":"Neoadjuvant Endocrine Therapy in Breast Cancer","status":"COMPLETED","sponsor":"Guangdong Provincial People's Hospital","startDate":"2012-09","conditions":"Highly Endocrine Responsive Operable Breast Cancer","enrollment":46},{"nctId":"NCT00329797","phase":"PHASE3","title":"Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2006-03","conditions":"Osteoporosis, Prostate Cancer","enrollment":109},{"nctId":"NCT00225420","phase":"PHASE1, PHASE2","title":"Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2005-08","conditions":"Prostate Cancer","enrollment":23},{"nctId":"NCT01642732","phase":"PHASE1","title":"Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer","status":"TERMINATED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2012-10","conditions":"Prostate Cancer","enrollment":1},{"nctId":"NCT01577199","phase":"PHASE4","title":"RCT of Low-dose Clomiphene vs. High Dose Gonadotropin Protocol for IVF Poor Responders","status":"WITHDRAWN","sponsor":"Weill Medical College of Cornell University","startDate":"2012-04","conditions":"Infertility","enrollment":""},{"nctId":"NCT02678520","phase":"PHASE2","title":"Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients","status":"WITHDRAWN","sponsor":"University of Kansas Medical Center","startDate":"2015-12","conditions":"Prostate Cancer","enrollment":""},{"nctId":"NCT00016913","phase":"PHASE2","title":"Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2001-05","conditions":"Prostate Cancer","enrollment":34},{"nctId":"NCT02813239","phase":"","title":"Dual Triggering in Patients With a High Immature Oocyte Rate","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2014-11","conditions":"INFERTILITY","enrollment":81},{"nctId":"NCT02706470","phase":"PHASE2, PHASE3","title":"Use of Cyclosporin A for the Treatment of Recurrent Miscarriage","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2016-05","conditions":"Miscarriage, Recurrent","enrollment":384},{"nctId":"NCT01603420","phase":"PHASE2, PHASE3","title":"External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer","status":"TERMINATED","sponsor":"Proton Collaborative Group","startDate":"2012-07","conditions":"Prostate Cancer","enrollment":2},{"nctId":"NCT01973842","phase":"PHASE2","title":"Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients","status":"UNKNOWN","sponsor":"Aristotle University Of Thessaloniki","startDate":"2014-02","conditions":"Subfertility","enrollment":90},{"nctId":"NCT00067015","phase":"PHASE3","title":"Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-05","conditions":"Prostate Cancer","enrollment":3},{"nctId":"NCT02635607","phase":"NA","title":"Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol","status":"UNKNOWN","sponsor":"Chong Qing Reproducive and Genetic Institute","startDate":"2016-01","conditions":"Infertility","enrollment":200},{"nctId":"NCT00796289","phase":"PHASE2","title":"Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2009-02","conditions":"Infertility","enrollment":350},{"nctId":"NCT01923194","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2013-10","conditions":"Anovulation","enrollment":215}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Gonal F or Follistim"],"phase":"marketed","status":"active","brandName":"High dose gonadotropins","genericName":"High dose gonadotropins","companyName":"Weill Medical College of Cornell University","companyId":"weill-medical-college-of-cornell-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"High dose gonadotropins stimulate the ovaries to produce multiple mature eggs for assisted reproductive procedures. Used for Controlled ovarian hyperstimulation for in vitro fertilization (IVF), Assisted reproductive technology (ART) procedures.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}